Pancreatic ductal adenocarcinoma
VCN-01 Plus Chemotherapy Receives FDA Orphan Drug Designation for Early PDAC Treatment
SG Tylor
Source – Theriva Biologics On 28June 2023, the FDA has granted Orphan Drug Designation (ODD) to VCN-01 in combination with ...
Combining mitazalimab with chemotherapy demonstrates significant antitumor activity in metastatic pancreatic ductal adenocarcinoma
SG Tylor
Source – Alligator Bioscience On June 26, 2023 the combination of mitazalimab, a novel CD40 monoclonal antibody agonist, with chemotherapy ...
